BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT ...Middle East

MINNEAPOLIS, Jan. 5, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024. Dr. McManus succeeds Kim Kelderman, who will become Bio-Techne's Chief Executive...

Hence then, the article about bio techne announces appointment of matthew f mcmanus as president diagnostics and genomics segment was published today ( Friday 05/01/2024 - 03:04 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT )

Also on site :

• '80s Hard Rock Band Announces Massive 2026 Tour With Iconic Special Guest
• 17 Athletes to Watch at the 2026 Winter Olympics—Including Lindsey Vonn’s Historic Return
• LIVE: Villarreal vs Real Madrid – La Liga